VIMTA offers analytical support to evaluate new drug products in development with marketed drug products of the same therapeutic class. The comparator studies also provide reference point for clinical trials by helping in analysis of relative bioequivalence, efficacy and safety.
Featured Service
Fast, Reliable Gene‑to‑Clinic Development
Bring your biologic program to life with an end‑to‑end CRADS platform
View service
